Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues

Pingyangmycin is a clinically used anticancer drug and induces lung fibrosis in certain cancer patients. We previously reported that the negatively charged cell surface glycosaminoglycans are involved in the cellular uptake of the positively charged pingyangmycin. However, it is unknown if pingyangm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Ying, Li, Xiulian, Liu, Yong, He, Yanli, Hao, Cui, Wang, Hua, Jin, Liying, Zhang, Guoqing, Zhang, Shufeng, Zhou, Aimin, Zhang, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131950/
https://www.ncbi.nlm.nih.gov/pubmed/32068946
http://dx.doi.org/10.1111/jcmm.15017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131950/
https://www.ncbi.nlm.nih.gov/pubmed/32068946
http://dx.doi.org/10.1111/jcmm.15017

Ejemplares similares